In Brief: Biopool
This article was originally published in The Gray Sheet
Biopool: Receives 510(k) clearance to market its Chromolize kit for measuring the level of tissue plasminogen activator (tPA) in blood. The kit includes Biopool's Stabilyte blood collection tubes, used to stabilize tPA during blood collection for accurate tPA measurements. Measurement of tPA, which correlates with fibrinolytic (blood clot formation) potential, aids in evaluating thrombotic tendencies such as myocardial infarction, pulmonary embolism, deep-vein thrombosis and unstable angina...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.